Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI -1.11%77 ROA % is 3.80% as of Mar. 2026, which is 55% below its 10-year median of 8.43. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 77/100 and a GF Value™ of ₹120.61 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 855 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 71.7% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. QMS Medical Allied Services's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹81 Mil.
QMS Medical Allied Services's average Total Assets over the quarter that ended in Mar. 2026 was ₹2,128 Mil. Therefore, QMS Medical Allied Services's annualized ROA % for the quarter that ended in Mar. 2026 was 3.80%.
The historical rank and industry rank for QMS Medical Allied Services's ROA % or its related term are showing as below:
NSE:QMSMEDI'
s ROA % Range Over the Past 10 Years
Min: 5.5 Med: 8.43 Max: 23.26
Current: 5.5
During the past 7 years, QMS Medical Allied Services's highest ROA % was 23.26%. The lowest was 5.50%. And the median was 8.43%.
NSE:QMSMEDI's ROA % is ranked better than 71.7% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs NSE:QMSMEDI: 5.50
QMS Medical Allied Services (NSE:QMSMEDI) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's ROA % distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
QMS Medical Allied Services (NSE:QMSMEDI) has a ROA % of 3.80% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on QMS Medical Allied Services and its competitors. This is 55% below median its historical median of 8.43. Over the past decade, QMS Medical Allied Services' ROA % has ranged from 5.50 to 23.26. According to the industry distribution chart, QMS Medical Allied Services ranks #242 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 28.3%.
Is QMS Medical Allied Services' ROA % too high?
QMS Medical Allied Services' current ROA % of 3.80% is 55% below median its 10-year median of 8.43. Over the past 10 years, this metric has ranged from a low of 5.50 to a high of 23.26. The Medical Devices & Instruments industry median ROA % is 0.56. QMS Medical Allied Services' value of 3.80% is 578.6% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #242 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #242 out of 855 companies for ROA %. This puts QMS Medical Allied Services in the upper half of its industry. The industry median ROA % is 0.56. QMS Medical Allied Services' value of 3.80% is 578.6% above this benchmark. Historically, QMS Medical Allied Services' own ROA % has ranged from 5.50 to 23.26 over the past decade. While the company's 10-year median is 8.43 vs. the industry median of 0.56, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current ROA % of 3.80% is 578.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current ROA % is 3.80%, which is 55% below median its own 10-year median of 8.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹120.61, compared to a current price of ₹106.96 — trading 11.3% below its estimated fair value. The current ROA % is 3.80%, which is 55% below median its 10-year median of 8.43 and 578.6% above the Medical Devices & Instruments industry median of 0.56. QMS Medical Allied Services' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current ROA % is 3.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹106.96 is trading 11.3% below its estimated GF Value™ of ₹120.61.
GuruFocus considers QMS Medical Allied Services to be Modestly Undervalued.
Key valuation signals for NSE:QMSMEDI:
ROA %: 3.80% (55% below median its 10-year median of 8.43)
GF Value™: ₹120.61 vs. price of ₹106.96 (11.3% below fair value)
Industry Position: 578.6% above the Medical Devices & Instruments median (#242 of 855)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
77GF Score
Get the complete analysis for NSE:QMSMEDI
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
